Nanomedicine in Translational Research: Status and Future Challenges

Dr. Kamalasanan is a Professor in the Department of Pharmaceutics, Amrita School of Pharmacy. He is the lead author of Roadmap for Biomaterials in Vision 2035 document by TIFAC, DST, India. He is an Industrial Pharmacist from Annamalai University and got trained in Biomaterials and Biomedical Engineering under Dr. Chandra P. Sharma at SCTIMST. He got trained in immunology under Prof. Harald Renz at Philipps University in Marburg, Germany. Later, he did three-year postdoctoral research with Dr. Steven R Little in interdisciplinary areas of immunotherapeutics, nanotechnology, and drug delivery at McGowan Institute for Regenerative Medicine and the Department of Chemical Engineering, Bioengineering, and Immunology, University of Pittsburgh, USA. After returning to India, he served as Chitra High Value Fellow Scientist-D at SCTIMST, India, for three years before moving to Amrita School of Pharmacy at Kochi, and is currently consulting for various organizations nationally and internationally. Dr. Kamalasanan has developed products that reached market filed several national and international patents, received numerous awards, and has several research articles, book chapters, and conference proceedings. He also actively participated in various professional society activities and has nearly 2 decades of research, technology development, and academic experience in translational medicine.

Dr. Chandra P. Sharma is Adjunct Professor, Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal University, and Hon. Emeritus Professor, College of Biomedical Engineering & Applied Sciences, Purbanchal University, Kathmandu, Nepal. Dr. Sharma is a Solid-State Physicist from IIT Delhi and received his training in Biomaterials area in the University of Utah with Prof. D.J. Lyman as a graduate student and in the University of Liverpool, England with Prof. D.F. Williams as a Post-Doctoral Research Associate. Dr. Sharma has been awarded FBSE (Fellow Biomaterials Science & Engineering) by The International Union of Societies for Biomaterials Science & Engineering (IUS-BSE) in 2008 and FBAO (Fellow Biomaterials and Artificial Organs) by Society for Biomaterials & Artificial Organs (India) (SBAOI) in 2011 and shares Whitaker and National Science Foundation Award – International Society for Artificial Organs (ISAO) USA, invited member ACS (2015-2018).